ADA Scientific Sessions 2026 Abstract

Mazdutide, a GCGR/GLP-1R Dual Agonist, Alleviates MASH and Liver Fibrosis through Hepatocytes–Hepatic Stellate Cells Cross Talk

By Ling Feng Zhang, Hui Wang, Ling Li, Hu-Lin Jiang

Experiments in animalsInterventions

The paper

Ling Feng Zhang, Hui Wang, Ling Li, Hu-Lin Jiang

Nanjing

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 2505-P

doi.org/10.2337/db26-2505-p

Journal of Cachexia, Sarcopenia and Muscle5 Oct 2026
A 5:2 fasting regimen curbs muscle impairment in mice
Nature Metabolism2 Oct 2026
Dasatinib and quercetin reduce liver fibrosis in a phase-2 MASH trial
Advanced Science2 Oct 2026
Alternate-day fasting curbs liver fibrosis in mice
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial